For The Better

Palantir is gaining traction among U.S. commercial customers, which is great news for shareholders.

DexCom now trades at a drastically lower earnings multiple than it has in the past.

Stock prices are starting to slide and that’s a long-term investor’s opportunity.

Palantir is succeeding as a company, but is the stock already too expensive?

Millennial and Gen Z eating habits could mean huge investment returns from these two growth stocks.

Perhaps other shareholders should unload the tech giant’s equity, too.

An AI-fueled recovery in the smartphone market could boost this chipmaker’s prospects over the next three years.

Paying a high premium for Novo Nordisk stock may be justifiable based on the company’s significant growth opportunities.

The market opportunity for DraftKings is growing rapidly, and the company has a market leader advantage.

Amazon stock slid after earnings, but does it really mean anything?

This dominant retailer has done a wonderful job rewarding its shareholders over the years.

The coffeehouse giant is hoping to quickly turn things around.

Rivian says it will get to industry-leading margins, but that may not be possible.

This smaller Nvidia peer seems to be gaining some ground in the market for AI chips deployed in data centers.

It’s important to look beyond what’s happening today.

Coinbase’s exchange business is slowing, but this segment continues to grow.

Two successful fund managers are ignoring Wall Street’s obsession with artificial intelligence (AI) stocks, investing in these bargain opportunities instead.

Guidance was disappointing, but the opportunity for Mobileye seems to be getting bigger.

Carvana is out of trouble, at least for now.

Berkshire Hathaway’s Q2 earnings are sending strong signals to investors.